This week’s Research Roundup highlights how fasting blood glucose levels provide an estimate of duration and progression of pancreatic cancer before diagnosis.
This week’s Research Roundup highlights gastrointestinal and extra-intestinal manifestations of immunoglobulin G4-related disease.
This week’s Research Roundup features highly discriminant methylated DNA markers for the non-endoscopic detection of Barrett's esophagus.
This week’s Research Roundup highlights how fasting blood-glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis.
This week’s Research Roundup highlights the development of a microscopic colitis disease activity index.
In a recent issue of Mayo Clinic's Digestive Diseases, Michael Camilleri, M.D., a gastroenterologist at Mayo Clinic, and Leslie Donato, Ph.D., Co-Director for Cardiovascular Laboratory Medicine, Hospital Clinical Laboratory, and Point of Care Testing at Mayo Clinic, discuss bile acid malabsorption testing in clinical practice.
In this month’s “Hot Topic,” Melissa Snyder, Ph.D., will review the diagnostic testing algorithms for celiac disease and highlight the advantages and limitations of certain tests, including serology and genetic assays.
Leslie Donato, Ph.D., Consultant in Cardiovascular Laboratory Medicine and Clinical Core Laboratory at Mayo Clinic, recently authored an article in "Medical Lab Management" on new laboratory testing options to evaluate irritable bowel syndrome with diarrhea (IBS-D) patients.
This week’s Research Roundup highlights prehospital transfusion for gastrointestinal bleeding.
This "Specialty Testing" webinar will outline the different tests to detect patients who are at risk for thiopurine-related toxicity and the advantages of each test.
Ann Moyer, M.D., Ph.D., discusses an additional gene, NUDT15, which is important in the prediction of thiopurine-related toxicity This gene has been added to our TPMT genotyping assay available through Mayo Medical Laboratories.
This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.